Paul Schulman

Paul Schulman is a Founding Partner of Senpoint Partners, bringing more than three decades of experience advising boards and management teams on mergers and acquisitions, shareholder activism, proxy contests and complex transactions. He has advised U.S. and international companies across a broad range of industries and market capitalizations.

Prior to co-founding Senpoint, Paul was Co-Head of the M&A and Activism Advisory Group at Sodali & Co (formerly Morrow Sodali). He joined that firm in 2020 after spending a decade at MacKenzie Partners.

Paul has advised on more than 1,000 contested and special situations, including Procter & Gamble’s proxy contest with Trian Partners; AT&T’s engagement with activist investor Elliott Management; Dell’s contested going-private transaction; Boots Capital’s proxy contest at Crown Castle; Canadian Pacific’s proxy contest with Pershing Square; Texas Pacific Land’s proxy contest with an investor group; and contested transactions involving Magellan Midstream and ONEOK, Abcam and Danaher, Consolidated Communications and Searchlight Capital, Verizon and Frontier Communications, Radius Health and Gurnet Point / Patient Square; Paratek Pharmaceuticals acquisition by Gurnet Point and Novo Holdings, Meltwater’s transaction with Marlin Equity Partners and the acquisition of Kindred Healthcare by a private equity consortium.

In addition to his work in North America, Paul has extensive experience advising on complex situations around the globe. He has handled more than 30 special situations in China alone, including proxy fights for control at Sinovac, Global Cord Blood and ChinaCast Education, as well as contested merger votes involving Hollysys, Yongye, 3SBio, Harbin Electric and Newater. He has also advised on several of Israel’s highest-profile transactions, including several hostile and contested takeover assignments for Stratasys and Ceragon.

Paul has provided expert testimony concerning closed-end fund governance on behalf of both Eaton Vance and BlackRock in separate litigation against Saba Capital.

Paul earned a Bachelor of Science in Chemical Engineering from Tulane University.